At the beginning of this year, two comparative effectiveness studies based on SCQM data were published in the Annals of Rheumatic Disease. In the first study, Sophie Martin Du Pan and others observe and improved drug retention in Rheumatoid Arthrtisi patients switching from anti-TNF to a biologic with another mode of action as compared to those switching from anti-TNF to anti-TNF. The second study, by Axel Finckh and others, describes that, although the evolution of disease activity was more favorable after a previous failure on anti-TNF with Rituximab than with another anti-TNF, the radiographic rate of progression in these patients could not be distinguished. Furthermore, a study by Delphine Courvoisier and others, using registry data from the United States and from the SCQM, analyzed the evolution of psychosocial health. They found that pain explained more of the psychosocial health evolution than functional disability (HAQ) or disease activity (RADAI).

To read the abstracts on these publications, please click here.